Literature DB >> 9038168

RalGDS functions in Ras- and cAMP-mediated growth stimulation.

M J Miller1, S Prigent, E Kupperman, L Rioux, S H Park, J R Feramisco, M A White, J L Rutkowski, J L Meinkoth.   

Abstract

Thyroid-stimulating hormone stimulates proliferation through both the cAMP-dependent protein kinase and Ras but not through Raf-1 and mitogen-activated and extracellular signal-related kinase kinase. We now report that thyroid-stimulating hormone represses mitogen-activated protein kinase activity and that microinjection of an effector domain mutant Ha-Ras protein, Ras(12V,37G), defective in Raf-1 binding and mitogen-activated protein kinase activation, stimulates DNA synthesis in quiescent and thyroid-stimulating hormone-treated thyrocytes. A yeast two-hybrid screen identified RalGDS as a Ras(12V,37G) binding protein and therefore a potential effector of Ras in these cells. Associations between Ras and RalGDS were observed in extracts prepared from thyroid cells. Microinjection of a mutant RalA(28N) protein thought to sequester RalGDS family members reduced DNA synthesis stimulated by Ras as well as cAMP-mediated DNA synthesis in two cell lines which respond to cAMP with mitogenesis. These results support the idea that RalGDS may be an effector of Ras in cAMP-mediated growth stimulation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9038168     DOI: 10.1074/jbc.272.9.5600

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  The Ras mutant D119N is both dominant negative and activated.

Authors:  R H Cool; G Schmidt; C U Lenzen; H Prinz; D Vogt; A Wittinghofer
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Ral-specific guanine nucleotide exchange factor activity opposes other Ras effectors in PC12 cells by inhibiting neurite outgrowth.

Authors:  T Goi; G Rusanescu; T Urano; L A Feig
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

3.  Ral GTPases contribute to regulation of cyclin D1 through activation of NF-kappaB.

Authors:  D O Henry; S A Moskalenko; K J Kaur; M Fu; R G Pestell; J H Camonis; M A White
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

4.  Protein kinase A-dependent and -independent signaling pathways contribute to cyclic AMP-stimulated proliferation.

Authors:  L A Cass; S A Summers; G V Prendergast; J M Backer; M J Birnbaum; J L Meinkoth
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

5.  Coordinated regulation of Rap1 and thyroid differentiation by cyclic AMP and protein kinase A.

Authors:  O M Tsygankova; A Saavedra; J F Rebhun; L A Quilliam; J L Meinkoth
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

6.  Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways.

Authors:  Y Ward; W Wang; E Woodhouse; I Linnoila; L Liotta; K Kelly
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

7.  Involvement of phosphoinositide-3-kinase and p70 S6 kinase in regulation of proliferation of rat lactotrophs in culture.

Authors:  K Kawashima; K Yamakawa; J Arita
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

8.  Phosphatidylinositol 3-kinase, protein kinase B and ribosomal S6 kinases in the stimulation of thyroid epithelial cell proliferation by cAMP and growth factors in the presence of insulin.

Authors:  K Coulonval; F Vandeput; R C Stein; S C Kozma; F Lamy; J E Dumont
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

9.  RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival.

Authors:  Yuchen Chien; Michael A White
Journal:  EMBO Rep       Date:  2003-07-11       Impact factor: 8.807

Review 10.  Studies of the regulation and function of the Gs alpha gene Gnas using gene targeting technology.

Authors:  Lee S Weinstein; Tao Xie; Qing-Hong Zhang; Min Chen
Journal:  Pharmacol Ther       Date:  2007-04-21       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.